<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00661518</url>
  </required_header>
  <id_info>
    <org_study_id>ASAP</org_study_id>
    <nct_id>NCT00661518</nct_id>
  </id_info>
  <brief_title>PET/CT Imaging of Aneurysm Wall Inflammation</brief_title>
  <acronym>ASAP</acronym>
  <official_title>Imaging of Aneurysm Wall Inflammation Using Positron Emission Tomography.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Aneurysm development, progression and rupture are characterised by extensive&#xD;
      inflammation, dominated by the infiltration of T-cells, B-cells and macrophages. Recent&#xD;
      studies into the pathophysiology of aneurysm wall degradation suggest a close relation&#xD;
      between increased mechanical stress and the local activation of infiltrated lymphocytes and&#xD;
      macrophages. The non-invasive detection of aneurysm wall inflammation, using&#xD;
      18-fluorodeoxyglucose positron emission tomography (FDG-PET) might therefore provide valuable&#xD;
      information on the extend of the disease and could clarify the role of mechanical stress on&#xD;
      the propagation of aneurysm wall inflammation.&#xD;
&#xD;
      Objective: Correlation of FDG uptake and in vitro aneurysm wall tensile strength. (primary&#xD;
      objective). The effect of aneurysm sac depressurisation, after endovascular aneurysm repair,&#xD;
      on aneurysm wall inflammation (secondary objective).&#xD;
&#xD;
      Study design: Observational case series (pilot). Study population: Patients scheduled for&#xD;
      conventional (open) and endovascular aneurysm repair.&#xD;
&#xD;
      Main study parameters: Standard uptake value (SUV) measurements to asses FDG uptake in the&#xD;
      aneurysm wall and in vitro aneurysm wall strength (N/mm).&#xD;
&#xD;
      Nature and extent of the burden and risks associated with participation,&#xD;
&#xD;
      benefit and group relatedness: Patients scheduled for conventional (open) or endovascular&#xD;
      aneurysm repair are admitted to the hospital the day before surgery. At that point all&#xD;
      patients will be evaluated using FDG-PET. Although intake of sugar-free liquids is permitted,&#xD;
      glucose intake is restricted 6 hours prior to FDG-PET imaging. One hour after intravenous&#xD;
      injection of 200-220 MBq FDG, whole body emission and transmission images will be acquired.&#xD;
      To determine inflammation markers ( e.g. CRP), blood and urine samples will be collected&#xD;
      prior to the operation and again 6 weeks after surgery. For in vitro aneurysm wall tensile&#xD;
      strength testing wall specimens will be harvested during conventional aneurysm repair.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <primary_completion_date type="Anticipated">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients scheduled for conventional aneurysm repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Patients scheduled for endovascular aneurysm repair</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Population: At the Radboud University Nijmegen Medical Centre, approximately 80 patients&#xD;
        undergo prophylactic aneurysm repair each year. 10-15 patients are scheduled for&#xD;
        conventional ('open') repair the remaining 65-70 patients undergo endovascular aneurysm. We&#xD;
        therefore expect to finish including patients for both studies by the end of august 2008.&#xD;
        The study population will be comprised both male (Â± 80%) and female patients with an&#xD;
        abdominal aortic aneurysm.&#xD;
&#xD;
        Inclusion criteria&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
        -Diabetes Mellitus type 1 en 2&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  scheduled for conventional (10 patients) or endovascular (25 patients) aneurysm&#xD;
             repair.&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes Mellitus type 1 en 2&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maarten Truijers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maarten Truijers, MD</last_name>
    <phone>+31243613956</phone>
    <email>m.truijers@chir.umcn.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maarten Truijers, MD</last_name>
      <phone>+31243613956</phone>
      <email>M.truijers@chir.umcn.nl</email>
    </contact>
    <investigator>
      <last_name>Maarten Truijers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2008</verification_date>
  <study_first_submitted>April 14, 2008</study_first_submitted>
  <study_first_submitted_qc>April 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2008</study_first_posted>
  <last_update_submitted>April 14, 2008</last_update_submitted>
  <last_update_submitted_qc>April 14, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2008</last_update_posted>
  <responsible_party>
    <name_title>M. Truijers, MD</name_title>
    <organization>Radboud University Nijmegen Medical Centre</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

